FDA Approves Symbravo for Acute Treatment of Migraine in Adults
Symbravo can rapidly eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severity
Four in 10 Patients Receiving Chemo Develop Chronic Painful Neuropathy
Among patients with chemotherapy-induced peripheral neuropathy, those treated with platinum-based agents, taxanes had highest prevalence
Qigong Beneficial for Veterans With Chronic Low Back Pain
An eight-week, nonpharmacological intervention showed significant relationships with pain and biological outcomes
FDA Approves First New Non-Opioid Pain Pill in Decades
Distribution of Opioid Meds Lower in Majority Non-White Communities
In a recent study, majority non-White communities had at least 40 percent lower mean adjusted per-capita distribution than majority White communities
Many Very Preterm Infants Experience Pain
Authors note that smallest babies who were most exposed to pain may be undertreated
Guidelines Developed to Address Infections Tied to Regional Anesthesia
Recommendations based on risks associated with different settings and consider individual patient characteristics
Medical Use of Cannabis Tied to Higher Prevalence of Cannabis Use Disorder
Findings seen for younger adults across cannabis use disorder severity levels
Odds of Opioid Misuse Lower in States With Medical Cannabis Laws
For individuals reporting past-year cannabis use, decreased odds of opioid misuse observed in states with medical cannabis legalization
Gout Flares Often Underreported in U.S. Adults With Gout
Patients who are younger, less educated, with a lower Charlson Comorbidity Index score less likely to report flares
